Overview

Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease

Status:
Terminated

Trial end date:
2010-10-01

Target enrollment:
0

Participant gender:
All

Summary

The primary objective of the study was to examine the safety and tolerability of memantine in outpatients with moderate to severe Alzheimer's Disease.

Phase:

Phase 3

Accepts Healthy Volunteers?

Details

Lead Sponsor:

H. Lundbeck A/S

Treatments:

Memantine

Criteria

Inclusion Criteria:

- Ambulatory outpatients with moderate to severe dementia of the Alzheimer's type who
have completed the 24-week Study 10158 and who have a knowledgeable and reliable
caregiver who will accompany the patient to all clinic visits during the course of the
study.

Exclusion Criteria:

- Diseases/medication which judged by the investigator could interfere with the
assessments of safety, tolerability or efficacy.